Track the Acutus Medical, Inc. share price and the full directors' dealings record of the company, a listed equity based in United States. Shares are quoted on US US, under the authority of SEC (Form 4). Operating in the Health Care sector, Acutus Medical, Inc. has recorded 86 insider filings. Market capitalisation: €1.6m. The latest transaction was disclosed on 4 March 2024 (Retenue fiscale). Among the most active insiders: Roman David. Every trade is openly available.
86
Insider Decl.
0
Thresholds
€43m
8 ops.
Buy Volume
€32,369
1 ops.
Sell Volume
32Σ signal
Buys €43m€32,369 Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 24,274 of 25,936 companies
17.7
score / 100
Value
32
Quality
3
FCF yld·
Earn yld·
EV/EBITDA15.9x
ROE·
Gross mgn5.0%
Net mgn-47%
Debt/EBITDA15.9x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
3,165 shares@ US$0.7545.3% of flowFORM 4SEC:0001628280-23-010611:0
25 of 86 declarations
About Acutus Medical, Inc.
Acutus Medical, Inc. is a company focused on developing technologies for the diagnosis and treatment of heart diseases. It is listed on NASDAQ under the ticker symbol ACUS.